Market Overview
The global infertility treatment devices market size reached USD 474.9 Million in 2024 and is projected to reach USD 761.7 Million by 2033, with a CAGR of 5.12% during 2025-2033. The market growth is driven by rising infertility rates, technological advancements, delayed parenthood trends, and government initiatives increasing treatment accessibility.
Study Assumption Years
- Base Year: 2024
- Historical Year/Period: 2019-2024
- Forecast Year/Period: 2025-2033
Infertility Treatment Devices Market Key Takeaways
- The market size was USD 474.9 Million in 2024.
- The forecast CAGR is 5.12% for 2025-2033.
- Growing number of fertility clinics worldwide is a key growth driver.
- ART procedures like IVF using frozen embryos and donor eggs/sperm are increasingly common.
- Rising public-private investments and government support enhance treatment accessibility.
- Advanced technologies and declining fertility rates support expanding demand.
Sample Request Link: https://www.imarcgroup.com/Infertility-Treatment-Devices-Market/requestsample
Market Growth Factors
- A growing number of fertility centers across the world should grow the market. Sedentary lifestyles in their leading to chronic diseases, such as diabetes, obesity, and hypertension, are other key factors contributing to infertility. Lifestyle-related health issues increasingly prevail and drive the market's growth.
- ARTs especially IVF processes that use old cryopreserved embryos and donor gametes rise because there is more access to and use of infertility treatment equipment, more public-private investment, and government initiatives, resulting in market expansion that propels market growth.
- ART technologies like in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and cryopreservation advanced plus increased the success rates through encouraging couples to undergo ART procedures which fueled market growth. Some regions treat with IVF freely or in a subsidized way.
Market Segmentation
- By Type: Sperm Separation Devices, Ovum Aspiration Pumps, Sperm Analyzer Systems, Micromanipulator Systems, Incubators, Cryosystems, Imaging Systems, Microscopes, Others. Rising male infertility cases drive demand for sperm separation and analysis devices. Increased IVF cycles fuel ovum aspiration pump usage.
- By Patient Type: Female Infertility Treatment, Male Infertility Treatment. Female infertility growth is influenced by delayed motherhood and rising conditions like PCOS. Male infertility recognition increases demand for diagnostic tools like sperm analyzers and micromanipulation systems.
- By End User: Fertility Clinics, Hospitals and Other Healthcare Facilities, Clinical Research Institutes. Fertility clinics lead demand for ART-related devices; hospitals use diagnostic equipment; research institutes require advanced devices for innovation and testing.
- By Region: North America, United States, Canada, Asia-Pacific, China, Japan, India, South Korea, Australia, Indonesia, Others, Europe, Germany, France, United Kingdom, Italy, Spain, Russia, Others, Latin America, Brazil, Mexico, Others, Middle East and Africa. North America has notable demand due to high infertility and technological advances; Europe benefits from government support; Asia Pacific's large population and rising infertility rates create significant market potential.
Regional Insights
North America dominates due to innovation in medical devices and advanced infertility treatments like IVF and IUI. European countries provide government support for fertility treatments, and Asia Pacific's rising infertility rates amid large populations create major growth opportunities.
Recent Developments & News
- July 2024: Nikon Corporation unveiled the ECLIPSE Ti2-I Motorized Inverted Microscope for micro-insemination, reducing operation steps by about 75%.
- July 2024: Mira established an online Hormone Health Clinic for Fertility aiding conception difficulties.
- May 2024: May Health raised $25 million to support clinical trials for treating infertility caused by PCOS with a less invasive outpatient method.
Key Players
- Ab Scientific Ltd
- Cook Group Incorporated
- Coopersurgical Inc. (The Cooper Companies Inc.)
- Eppendorf
- Esco Micro Pte. Ltd.
- Genea Limited
- Hamilton Throne Ltd.
- Kitazato Corporation
- Rocket Medical plc
- Thermo Fisher Scientific
- Thomas Medical (Medgyn Products Inc.)
- Vitrolife
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
Request For Customization: https://www.imarcgroup.com/request?type=report&id=5710&flag=E
About Us
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us
IMARC Group,
134 N 4th St. Brooklyn, NY 11249, USA,
Email: sales@imarcgroup.com,
Tel No: (D) +91 120 433 0800,
United States: +1-201971-6302
Comments (0)